Analytical testing, QC

Bioanalytical CRO LGC adopts Quanterix’s automated analyzer for immunoassays

03-Oct-2019 By Vassia Barba

LGC announces the addition of Quanterix’s HD-X platform to its offering, enabling automated development and performing of immunoassays for ‘unprecedented insights’ into disease biology as well as drug efficacy and safety.

PPD expands bioanalytical lab, to hire 200

23-Sep-2019 By Melissa Fassbender

PPD is expanding its immunochemistry and biomarker space by 8,000 square feet, the addition of which will also support a dedicated team for one of the company’s global biopharmaceutical clients.

AI in drug development: ACRO, DIA, and Owkin to talk use cases and what comes next

18-Sep-2019 By Melissa Fassbender

There has been a lot of discussion surrounding the use of artificial intelligence in drug development – with several deals, alliances, and partnerships made so far this year. Here, Outsourcing-Pharma takes a look back at some of these announcements, as...

O2h to do ‘heavy lifting’ as part of synthetic chemistry collaboration with Cedilla

17-Sep-2019 By Melissa Fassbender

Cedilla Therapeutics and o2h Discovery have announced a multi full-time-equivalent (FTE) expansion to their synthetic chemistry collaboration.

Covance doubles capacity with new R&D center in China

12-Sep-2019 By Vassia Barba

Covance opens a new facility in Shanghai, its biggest in Asia Pacific, to boost its research and development services offering.

Charles River ups microbial solutions offering

12-Sep-2019 By Melissa Fassbender

Charles River has added to its microbial solutions offering with two new products that aim to reduce risk and increase the efficiency of drug testing.

What’s next for M&A? Precision medicine, diagnostics, new customers to disrupt pharma services market

06-Sep-2019 By Melissa Fassbender

Increasingly complex clinical trials are putting pressure on CROs to expand their service offerings in what has been a historically monolithic space – with diagnostics also continuing to play a more important role in the market, says industry expert.

Velesco acquires facility, triples clinical manufacturing capacity

05-Sep-2019 By Vassia Barba

Velesco to triple its capacity for non-sterile clinical material manufacturing and consolidate its cGMP capabilities with the purchase of a facility in Wixom, Michigan.

People on the Move: Outsourcing-Pharma roundup August ‘19

04-Sep-2019 By Melissa Fassbender

The last month of summer saw several hires, including a lead for Worldwide Clinical Trials’ Japan operations, CEO appointments at CordenPharma and LabConnect, and Altasciences’ new CSO, who joins the company from Syneos.

908 Devices launches a Rebel-lion in media analyzing

03-Sep-2019 By Vassia Barba

908 Devices launches Rebel, a bioprocess analyzer, enabling researchers to conduct their own cell culture media analysis to accelerate process development ‘by weeks’.

PCI boosts Ireland investment pre-Brexit with new clinical facility

27-Aug-2019 By Melissa Fassbender

As part of its global network expansion strategy, PCI Pharma Services is investing in a new dedicated clinical facility near Dublin, Ireland, which will provide space for secondary packaging, storage, logistics, and distribution.

Organ-on-e-chip tech circumvents challenge of reading the heart's electrical patterns

26-Aug-2019 By Maggie Lynch

Researchers develop organ-on-an-electronic-chip platform to explore the electrophysiology of iPSC-derived cardiomyocytes and understand how the heart communicates.

Ex vivo 3D cell culture tech makes ‘true drug response prediction’ possible: Kiyatec

19-Aug-2019 By Maggie Lynch

Capital Health joins Kiyatec’s clinical trial to validate a patient-specific predictor test to improve response to cancer therapies for glioblastoma and anaplastic astrocytoma.

SGS connecting systems, labs via fully digitalized global network

15-Aug-2019 By Maggie Lynch

SGS’ OneVision initiative is working to standardize record-keeping across the global life sciences industry in an aim to accelerate laboratory testing, development, and eliminate paper-based systems.

People on the Move: Outsourcing-Pharma roundup July ‘19

02-Aug-2019 By Melissa Fassbender

CordenPharma has a new CEO, Arbour Group advances plans to expand in RTP, Ashfield brings on a former Iqvia VP, and Recursion adds to its c-suite after raising $121m this month.